Scientific Director, PGT-IVF Business Unit, Eurofins Genoma, Italy
BIOGRAPHY
December 12, 2023 | 4PM CET, 7AM PST, 10AM EST
Roundtable: Non-invasive vs Invasive Preimplantation Genetic Testing (PGT)
Speakers
-
Sandrine Chamayou, PhD
Laboratory Director, Centro HERA - U.M.R., ItalyBIOGRAPHY -
Prof. Volkan Baltaci, MD, PhD
Laboratory Director, Mikrogen Genetic Diagnosis Center, TurkeyBIOGRAPHY -
Alok Tomar, PhD
Senior Manager Product Management, Reproductive Health, Thermo Fisher Scientific, USABIOGRAPHY
Event Date & Time
LIVE:
Date: December 12, 2023
Time: 4PM CET, 7AM PST, 10AM EST
Abstract
An estimated 48.5 million couples suffer from infertility worldwide, driving up usage of assisted reproductive technologies around the globe. As a result, preimplantation genetic testing (PGT), has become commonplace in vitro fertilization (IVF) research, to evaluate the status of an embryo. One significant distinction within PGT methods lies in their invasiveness. Non-invasive PGT techniques include comprehensive chromosome screening (CCS) and PGT for aneuploidy (PGT-A), whereas invasive methods include PGT for monogenic/single gene defects (PGT-M) or PGT for structural rearrangements (PGT-SR). This one-hour roundtable aims to explore the particulars of non-invasive and invasive PGT, offering a comparative analysis of their methods, benefits, limitations, and risks. Experts in the field will share their insights, helping participants understand the advancements, challenges, and prospects of PGT techniques.
Learning objectives
- Understand the importance of PGT in reproductive health
- Discover the latest non-invasive and invasive PGT techniques and applications
- Hear from experts highlighting respective advantages and limitations and addressing common concerns factors influencing the choice between these methods
- Explore upcoming trends and innovations in the field of PGT
- Introduction of the Thermo Fisher Scientific NGS based PGT research test
- Engage with our speakers in the Q&A session
Thermo Fisher Scientific and its affiliates are not endorsing, recommending or promoting any use or application of Thermo Fisher Scientific products by third parties during this seminar. Information and materials presented or provided by third parties as-is and without warranty of any kind, including regarding intellectual property rights and reported results.
Parties presenting images, text and material represent they have the right to do so.
You May Also Like
DEC 10, 2024 | 9:00 AM
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
OCT 02, 2024 | 7:30 AM
De novo gene synthesis and protein expression are established technologies that can give access to nearly any target DNA or protein sequence, allowing for engineering of biologics. In this p...
Loading Comments...